Ovodan Biotech A/S: Financial statements 2023
CVR: 33870256
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Ovodan Biotech A/S (CVR 33870256) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -157,221 and a net result of DKK 220,846 compared with DKK -1,530,961 the year before. Equity in the 2023 report amounted to DKK -20,505,840. The company had 2 employees in the financial year.
- Gross Profit
- DKK -157,221
- Profit/Loss
- DKK 220,846
- Equity
- DKK -20,505,840
- Total Assets
- DKK 1,815,269
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -157K | 221K | -20.5M | 2 |
| 2022 | - | -439K | -1.5M | -20.7M | 3 |
| 2021 | - | -741K | -2M | -19.2M | 3 |
| 2020 | - | -1.5M | -3.1M | -17.2M | 5 |
| 2019 | - | -1.8M | -2.9M | -14.1M | 4 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Ovodan Biotech A/S has published its annual report for 2022. Gross profit came to DKK -439,188, and the net result was DKK -1,530,961.
About Ovodan Biotech A/S
Ovodan Biotech A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SANOVO BIOTECH A/S. The management consists of Henrik Marinus Pedersen. The board consists of Thor Stadil (chair), Christian Nicholas Rosenkrantz Stadil and Henrik Marinus Pedersen. The company is owned by Ovodan Foods A/S. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -805,830 and a net result of DKK -1,201,387 compared with DKK -1,177,651 the year before. Equity in the 2025 report amounted to DKK -884,888.